APA (7th ed.) Citation

Yu, Z., Wang, L., Quan, M., Zhang, T., & Song, H. (2021). Successful management with Janus kinase inhibitor tofacitinib in refractory juvenile dermatomyositis: A pilot study and literature review. Rheumatology (Oxford, England), 60(4), 1700-1707. https://doi.org/10.1093/rheumatology/keaa558

Chicago Style (17th ed.) Citation

Yu, Zhongxun, Lin Wang, Meiying Quan, Tiannan Zhang, and Hongmei Song. "Successful Management with Janus Kinase Inhibitor Tofacitinib in Refractory Juvenile Dermatomyositis: A Pilot Study and Literature Review." Rheumatology (Oxford, England) 60, no. 4 (2021): 1700-1707. https://doi.org/10.1093/rheumatology/keaa558.

MLA (9th ed.) Citation

Yu, Zhongxun, et al. "Successful Management with Janus Kinase Inhibitor Tofacitinib in Refractory Juvenile Dermatomyositis: A Pilot Study and Literature Review." Rheumatology (Oxford, England), vol. 60, no. 4, 2021, pp. 1700-1707, https://doi.org/10.1093/rheumatology/keaa558.